title: A survey of cancer morbidity and mortality in vaccinees seven to 12 years after the administration of live vaccine propagated in human diploid cells.
abstract: Using record linkage, cancer morbidity and mortality were examined in 2973 recipients of RA 27/3 strain rubella vaccine propagated in WI 38 cells. During the follow-up reported (mean duration 9.8 years; range seven to 12 years) the rate of cancer notifications and of deaths from cancer were similar to those observed in the equivalent age range of the general population.
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002460:Cell Line; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009369:Neoplasms / Q000401:mortality*; D009374:Neoplasms, Experimental; D012411:Rubella Vaccine / Q000009:adverse effects*
chemical_list: D012411:Rubella Vaccine